Bladder Clear Cell Adenocarcinoma
1 clinical trials · Condition
◉ Watch Bladder Clear Cell Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors (NCT03866382) | National Cancer Institute (NCI) | 2019-05-13 |
Track Bladder Clear Cell Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.